Form 4: MKS Director Sells Shares Under 10b5-1 Plan

MKS Inc. Director Jacqueline F. Moloney sold 340.107 shares of common stock for a weighted average price of $213.7717 per share under a pre-arranged 10b5-1 plan.

Summary

• Jacqueline F. Moloney, a Director of MKS Inc. (MKSI), reported a sale of common stock.
• The transaction involved the disposition of 340.107 shares of MKS Inc. common stock.
• The shares were sold at a weighted average price of $213.7717 per share.
• Individual trade prices ranged from $213.7716 to $214.015.
• Following this transaction, Moloney beneficially owns 10,393.197 shares of MKS Inc. common stock directly.
• The transaction was executed on March 12, 2026, pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically indicates personal financial planning rather than a change in outlook on the company's prospects.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale not based on immediate insider information.

Negatives

• A director selling shares could be perceived negatively by some investors, although the 10b5-1 plan mitigates concerns about opportunistic timing.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for insights into management's perception of the company's valuation. While a 10b5-1 plan mitigates concerns about opportunistic timing, the sale by a director of a technology company like MKS Inc. could be viewed in the context of broader market trends or personal financial planning.

Comparison to Industry Standards

• This Form 4 filing reports a standard insider transaction. There are no specific comparable companies, projects, or results mentioned to assess against global benchmarks. Insider sales under 10b5-1 plans are common practice across industries for executives and directors to manage personal portfolios while adhering to insider trading regulations.

Stakeholder Impact

• Shareholders: May observe the director's sale, but the 10b5-1 plan suggests it's not based on new material information. The small volume relative to total shares outstanding is unlikely to have a significant direct impact.

Key Dates

Recommendation

The filing details a routine, pre-scheduled sale of a relatively small number of shares by a director under a 10b5-1 plan. This type of transaction is typically for personal financial management and does not inherently signal a change in the company's fundamental outlook or performance. Therefore, it provides no new information to warrant a change in investment thesis, suggesting a 'hold' recommendation for existing investors.

Keywords

MKS Inc., MKSI, Insider Trading, Form 4, Director Sale, Stock Sale, Jacqueline F. Moloney, 10b5-1 Plan, Equity Transaction